A family office called Grand View Investment was established in China in 2012. The Beijing-based Chinese institution engages in a range of financial activities, such as direct investments in domestic and international markets and the trading of securities. In the past, it has collaborated with private equity firms, business owners, and private banks.
Dan Sabourin, CEO
Private Equity, Private Debt, Real Estate, Infrastructure, Natural Resources , and Hedge Funds.
Latest investment was in SciClone Pharmaceuticals on Feb 19, 2021.